![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessCirculating biomarker correlates of left atrial size and myocardial extracellular volume fraction among persons living with and without HIV
Infection with human immunodeficiency virus (HIV) is associated with higher risk for myocardial disease despite modern combination antiretroviral therapy (cART). Factors contributing to this excess risk, howev...
-
Article
Author Correction: HIV and antiretroviral therapy-related fat alterations
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
-
Article
HIV and antiretroviral therapy-related fat alterations
Early in the HIV epidemic, lipodystrophy, characterized by subcutaneous fat loss (lipoatrophy), with or without central fat accumulation (lipohypertrophy), was recognized as a frequent condition among people l...
-
Article
HIV and Bone Complications: Understudied Populations and New Management Strategies
The higher risk of osteoporosis and fracture associated with HIV infection and certain antiretrovirals has been well established and the need for risk stratification among older adults increasingly recognized....
-
Article
Functional Impairment, Disability, and Frailty in Adults Aging with HIV-Infection
The integration of antiretroviral therapy (i.e., ART) into HIV care has dramatically extended the life expectancy of those living with HIV. However, in comparison to similar HIV-uninfected populations, HIV-inf...
-
Article
Management of the metabolic effects of HIV and HIV drugs
Body adipose tissue changes and metabolic abnormalities are common among HIV-infected patients receiving highly active antiretroviral therapy and contribute to the risk of cardiovascular disease. This Review h...